This grant, offered by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), is for eligible United States small businesses. Its primary purpose is to invite these businesses to submit Small Business Innovation Research (SBIR) grant applications. Applicants should possess the necessary research capabilities and technological expertise to significantly contribute to the research and development (R&D) missions of the NIH, CDC, and FDA awarding components. This specific funding opportunity focuses on innovative R&D projects. It is important to note that this Parent SBIR grant specifically excludes clinical trials, focusing instead on other research and development initiatives. The aim is to foster innovation within the small business sector to advance public health and medical science.
Opportunity ID: 334628
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-21-259 |
| Funding Opportunity Title: | PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Environment Food and Nutrition Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.068 — Chronic Diseases: Research, Control, and Prevention |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 08, 2021 |
| Last Updated Date: | Jul 08, 2021 |
| Original Closing Date for Applications: | Apr 05, 2022 |
| Current Closing Date for Applications: | Apr 05, 2022 |
| Archive Date: | May 11, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2021-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA. This Parent Funding Opportunity Announcement does not accept clinical trials. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-21-259.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 334628 Full Announcement-PA-21-259 -> PA-21-259-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00271834 | Jan 31, 2022 | Apr 05, 2022 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268112 | Aug 06, 2021 | Jan 24, 2022 | View |
Package 1
Mandatory forms
334628 RR_SF424_5_0-5.0.pdf
334628 PHS398_CoverPageSupplement_5_0-5.0.pdf
334628 RR_OtherProjectInfo_1_4-1.4.pdf
334628 PerformanceSite_4_0-4.0.pdf
334628 RR_KeyPersonExpanded_4_0-4.0.pdf
334628 RR_Budget_3_0-3.0.pdf
334628 PHS398_ResearchPlan_4_0-4.0.pdf
334628 SBIR_STTR_Information_3_0-3.0.pdf
334628 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334628 RR_SubawardBudget30_3_0-3.0.pdf
334628 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
334628 RR_SF424_2_0-2.0.pdf
334628 PHS398_CoverPageSupplement_5_0-5.0.pdf
334628 RR_OtherProjectInfo_1_4-1.4.pdf
334628 PerformanceSite_2_0-2.0.pdf
334628 RR_KeyPersonExpanded_2_0-2.0.pdf
334628 RR_Budget_1_4-1.4.pdf
334628 PHS398_ResearchPlan_4_0-4.0.pdf
334628 SBIR_STTR_Information_1_3-1.3.pdf
334628 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334628 RR_SubawardBudget30_1_4-1.4.pdf
334628 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
